Therefore, increasing stroke awareness through public educational campaigns has been widely advocated as a means to reduce pre-hospital delay and increase the potential for patient access to proven therapies, such as intravenous tissue plasminogen activator (tPA) [5]. This evidence concerns the gene PLAT and stroke disorder.